NRx, a niche drug company founded in 2009 by Dr. Deanna J. Nelson and headquartered in Cary, NC, reformulates important drugs to eliminate their side effects. Reformulation provides a patented drug that can be approved quickly by the FDA and enter a large existing market as a branded drug. Market entry by generic copies of the reformulated drug will be delayed by law for a period of 3 years or more. NRx will use the FDA’s 505(b)(2) New Drug Application process to commercialize NRx’s lead reformulated drug candidate MagneVal™, a patent-protected new treatment for epilepsy. NRx has 3 employees who will direct rapid FDA approval and drug commercialization at a cost at least 60% to 70% less than innovator products. The team will also ensure achievement of the long-term objectives of outstanding profitability and return on investment.
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nelsonrx.com
- Keywords
- Drug Development.
Nelson Pharmaceuticals, Llc Questions
Nelson Pharmaceuticals, Llc's website is nelsonrx.com
Nelson Pharmaceuticals, Llc's LinkedIn profile is https://www.linkedin.com/company/nelson-pharmaceuticals-llc
Nelson Pharmaceuticals, Llc's industry is
Biotechnology Research
Nelson Pharmaceuticals, Llc's top competitors are
Raft Pharmaceuticals,
Rich Pharmaceuticals, Inc.,
Tyna Pharmaceuticals Inc.,
L&l Insulations,
Mountain View Pharmaceuticals, Inc.,
Inspira Pharmaceuticals Limited,
Inflexion Pharmaceuticals Llc,
Ernest Pharmaceuticals,
Sacyl Pharmaceuticals, Inc.,
Millenium Pharmaceuticals.
Nelson Pharmaceuticals, Llc's categories are Biotechnology Research
Nelson Pharmaceuticals, Llc's founding year is 2009
